Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Clinical proteomics of enervated neurons.
Berlex continues legal challenge to FDA over MS drug.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Comprehensive Immunophenotyping of CSF cells in relapsing-remitting multiple sclerosis patients with daclizumb therapy
Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus - induced demyelinating disease by modifying Nrf2-Keap1 pathway.
Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a.
Synaptic pathology: a shared mechanism in neurological disease.
Nanoparticle transport across the blood brain barrier.
Vision Disturbances in Multiple Sclerosis.
Mitoxantrone: benefits and risks in multiple sclerosis patients.
Pushing Forward: Remyelination as the New Frontier in CNS Diseases.
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.
Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.
Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.
American Society for Neurochemistry Annual Meeting
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
Improvements in cognition, quality of life, and physical performance with clinical Pilates in multiple sclerosis: a randomized controlled trial.
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica.
Advanced Structural and Functional Brain MRI in Multiple Sclerosis.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.

Pages